|
1
|
Foy PM, Copeland GP and Shaw MD: The
incidence of postoperative seizures. Acta Neurochir (Wien).
55:253–264. 1981.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Manaka S, Ishijima B and Mayanagi Y:
Postoperative seizures: Epidemiology, pathology, and prophylaxis.
Neurol Med Chir (Tokyo). 43:589–600; discussion 600.
2003.PubMed/NCBI View Article : Google Scholar
|
|
3
|
North JB, Penhall RK, Hanieh A, Frewin DB
and Taylor WB: Phenytoin and postoperative epilepsy. A double-blind
study. J Neurosurg. 58:672–677. 1983.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Temkin NR: Prophylactic anticonvulsants
after neurosurgery. Epilepsy Curr. 2:105–107. 2002.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Lee ST, Lui TN, Chang CN, Cheng WC, Wang
DJ, Heimburger RF and Lin CG: Prophylactic anticonvulsants for
prevention of immediate and early postcraniotomy seizures. Surg
Neurol. 31:361–364. 1989.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Wu AS, Trinh VT, Suki D, Graham S, Forman
A, Weinberg JS, McCutcheon IE, Prabhu SS, Heimberger AB, Sawaya R,
et al: A prospective randomized trial of perioperative seizure
prophylaxis in patients with intraparenchymal brain tumors. J
Neurosurg. 118:873–883. 2013.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Rudà R, Bello L, Duffau H and Soffietti R:
Seizures in low-grade gliomas: Natural history, pathogenesis, and
outcome after treatments. Neuro Oncol. 14 (Suppl 4):iv55–iv64.
2012.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Vecht CJ and Wilms EB: Seizures in low-
and high-grade gliomas: Current management and future outlook.
Expert Rev Anticancer Ther. 10:663–669. 2010.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Walbert T, Harrison RA, Schiff D, Avila
EK, Chen M, Kandula P, Lee JW, Le Rhun E, Stevens GHJ, Vogelbaum
MA, et al: SNO and EANO practice guideline update: Anticonvulsant
prophylaxis in patients with newly diagnosed brain tumors. Neuro
Oncol. 23:1835–1844. 2021.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Iuchi T, Kuwabara K, Matsumoto M, Kawasaki
K, Hasegawa Y and Sakaida T: Levetiracetam versus phenytoin for
seizure prophylaxis during and early after craniotomy for brain
tumours: A phase II prospective, randomised study. J Neurol
Neurosurg Psychiatry. 86:1158–1162. 2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Konrath E, Marhold F, Kindler W, Scheichel
F, Popadic B, Blauensteiner K, Calabek B, Freydl E, Weber M, Ristl
R, et al: Perioperative levetiracetam for seizure prophylaxis in
seizure-naive brain tumor patients with focus on neurocognitive
functioning. BMC Neurol. 22(250)2022.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Dircio-Bautista M, Colín-González AL,
Aguilera G, Maya-López M, Villeda-Hernández J, Galván-Arzate S,
García E, Túnez I and Santamaría A: The antiepileptic drug
levetiracetam protects against quinolinic acid-induced toxicity in
the rat striatum. Neurotox Res. 33:837–845. 2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Vogl C, Mochida S, Wolff C, Whalley BJ and
Stephens GJ: The synaptic vesicle glycoprotein 2A ligand
levetiracetam inhibits presynaptic Ca2+ channels through an
intracellular pathway. Mol Pharmacol. 82:199–208. 2012.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Fuller KL, Wang YY, Cook MJ, Murphy MA and
D'Souza WJ: Tolerability, safety, and side effects of levetiracetam
versus phenytoin in intravenous and total prophylactic regimen
among craniotomy patients: A prospective randomized study.
Epilepsia. 54:45–57. 2013.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Hanada T, Hashizume Y, Tokuhara N,
Takenaka O, Kohmura N, Ogasawara A, Hatakeyama S, Ohgoh M, Ueno M
and Nishizawa Y: Perampanel: A novel, orally active, noncompetitive
AMPA-receptor antagonist that reduces seizure activity in rodent
models of epilepsy. Epilepsia. 52:1331–1340. 2011.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Yamamoto T, Gil-Nagel A, Wheless JW, Kim
JH and Wechsler RT: Perampanel monotherapy for the treatment of
epilepsy: Clinical trial and real-world evidence. Epilepsy Behav.
136(108885)2022.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Eisai News Release. Approval of
antiepileptic drug Fycompa® in Japan for monotherapy and
pediatric indications for partial-onset seizures, as well as a new
formulation. Available at: https://www.eisai.com/news/2020/news202004.html.
Accessed April 12, 2024.
|
|
18
|
Heugenhauser J, Iglseder S, Muigg A,
Kerschbaumer J, Stockhammer G, Nowosielski M and Unterberger I:
Perampanel in brain tumor and SMART-syndrome related epilepsy-A
single institutional experience. J Neurol Sci.
423(117386)2021.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Maschio M, Zarabla A, Maialetti A,
Giannarelli D, Koudriavtseva T, Villani V and Zannino S: Perampanel
in brain tumor-related epilepsy: Observational pilot study. Brain
Behav. 10(e01612)2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Kusakabe K, Inoue A, Watanabe H, Nakamura
Y, Nishikawa M, Ohtsuka Y, Ogura M, Shigekawa S, Taniwaki M,
Kitazawa R and Kunieda T: Perioperative perampanel administration
for early seizure prophylaxis in brain tumor patients. Surg Neurol
Int. 14(287)2023.PubMed/NCBI View Article : Google Scholar
|
|
21
|
WHO Classification of Tumours Editorial
Board. World Health Organization Classification of Tumours of the
Central Nervous System. 5th edition. International Agency for
Research on Cancer, 2021.
|
|
22
|
Common Terminology Criteria for Adverse
Events (CTCAE). Version 5. Published: November 27. US Department of
Health and Human Services, National Institutes of Health, National
Cancer Institute, 2017.
|
|
23
|
Fisher RS, Cross JH, D'Souza C, French JA,
Haut SR, Higurashi N, Hirsch E, Jansen FE, Lagae L, Moshé SL, et
al: Instruction manual for the ILAE 2017 operational classification
of seizure types. Epilepsia. 58:531–542. 2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
von Elm E, Altman DG, Egger M, Pocock SJ,
Gøtzsche PC and Vandenbroucke JP: STROBE Initiative. The
strengthening the reporting of observational studies in
epidemiology (STROBE) Statement: Guidelines for reporting
observational studies. BMJ. 335:806–808. 2007.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Toledano Delgado R, García-Morales I,
Parejo-Carbonell B, Jiménez-Huete A, Herrera-Ramirez D,
González-Hernández A, Ayuga Loro F, Santamarina E, Toledo M, Ojeda
J, et al: Effectiveness and safety of perampanel monotherapy for
focal and generalized tonic-clonic seizures: Experience from a
national multicenter registry. Epilepsia. 61:1109–1119.
2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Chinvarun Y: A retrospective, real-world
experience of perampanel monotherapy in patient with first new
onset focal seizure: A Thailand experience. Epilepsia Open.
7:67–74. 2022.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Gil-Nagel A, Burd S, Toledo M, Sander JW,
Lebedeva A, Patten A and Laurenza A: Study 504 investigator group:
A retrospective, multicentre study of perampanel given as
monotherapy in routine clinical care in people with epilepsy.
Seizure. 54:61–66. 2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Wechsler RT, Wheless J, Zafar M, Huesmann
GR, Lancman M, Segal E, Chez M, Aboumatar S, Patten A, Salah A and
Malhotra M: PROVE: Retrospective, non-interventional, phase IV
study of perampanel in real-world clinical care of patients with
epilepsy. Epilepsia Open. 7:293–305. 2022.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Greenhalgh J, Weston J, Dundar Y, Nevitt
SJ and Marson AG: Antiepileptic drugs as prophylaxis for
postcraniotomy seizures. Cochrane Database Syst Rev.
5(CD007286)2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Joiner EF, Youngerman BE, Hudson TS, Yang
J, Welch MR, McKhann GM, Neugut AI and Bruce JN: Effectiveness of
perioperative antiepileptic drug prophylaxis for early and late
seizures following oncologic neurosurgery: A meta-analysis. J
Neurosurg. 130:1274–1282. 2018.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Nossek E, Matot I, Shahar T, Barzilai O,
Rapoport Y, Gonen T, Sela G, Korn A, Hayat D and Ram Z: Failed
awake craniotomy: A retrospective analysis in 424 patients
undergoing craniotomy for brain tumor. J Neurosurg. 118:243–249.
2013.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Dewan MC, Thompson RC, Kalkanis SN, Barker
FG II and Hadjipanayis CG: Prophylactic antiepileptic drug
administration following brain tumor resection: Results of a recent
AANS/CNS section on tumors survey. J Neurosurg. 126:1772–1778.
2017.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Motomura K, Chalise L, Shimizu H,
Yamaguchi J, Nishikawa T, Ohka F, Aoki K, Tanahashi K, Hirano M,
Wakabayashi T and Natsume A: Intraoperative seizure outcome of
levetiracetam combined with perampanel therapy in patients with
glioma undergoing awake brain surgery. J Neurosurg. 135:998–1007.
2021.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Hildebrand J, Lecaille C, Perennes J and
Delattre JY: Epileptic seizures during follow-up of patients
treated for primary brain tumors. Neurology. 65:212–215.
2005.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Yin X, Yang J, Zhang M, Wang X, Xu W,
Price CH, Huang L, Liu W, Su H, Wang W, et al: Serum metabolic
fingerprints on bowl-shaped submicroreactor chip for chemotherapy
monitoring. ACS Nano. 16:2852–2865. 2022.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Zhu H, Yang C, Yan A, Qiang W, Ruan R, Ma
K, Guan Y, Li J, Yu Q, Zheng H, et al: Tumor-targeted
nano-adjuvants to synergize photomediated immunotherapy enhanced
antitumor immunity. View. 4(20220067)2023.
|
|
37
|
Tamura R: Drug repositioning for
refractory benign tumors of the central nervous system. Int J Mol
Sci. 24(12997)2023.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Venkataramani V, Tanev DI, Strahle C,
Studier-Fischer A, Fankhauser L, Kessler T, Körber C, Kardorff M,
Ratliff M, Xie R, et al: Glutamatergic synaptic input to glioma
cells drives brain tumour progression. Nature. 573:532–538.
2019.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Grossman SA, Ye X, Chamberlain M,
Mikkelsen T, Batchelor T, Desideri S, Piantadosi S, Fisher J and
Fine HA: Talampanel with standard radiation and temozolomide in
patients with newly diagnosed glioblastoma: A multicenter phase II
trial. J Clin Oncol. 27:4155–4161. 2009.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Salmaggi A, Corno C, Maschio M, Donzelli
S, D'Urso A, Perego P and Ciusani E: Synergistic effect of
perampanel and temozolomide in human glioma cell lines. J Pers Med.
11(390)2021.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Heuer S, Burghaus I, Gose M, Kessler T,
Sahm F, Vollmuth P, Venkataramani V, Hoffmann D, Schlesner M,
Ratliff M, et al: PerSurge (NOA-30) phase II trial of perampanel
treatment around surgery in patients with progressive glioblastoma.
BMC Cancer. 24(135)2024.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Tabaee Damavandi P, Pasini F, Fanella G,
Cereda GS, Mainini G, DiFrancesco JC, Trinka E and Lattanzi S:
Perampanel in brain tumor-related epilepsy: A systematic review.
Brain Sci. 13(326)2023.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Vivero M, Doyle LA, Fletcher CD, Mertens F
and Hornick JL: GRIA2 is a novel diagnostic marker for solitary
fibrous tumour identified through gene expression profiling.
Histopathology. 65:71–80. 2014.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Sarver AE, Sarver AL, Thayanithy V and
Subramanian S: Identification, by systematic RNA sequencing, of
novel candidate biomarkers and therapeutic targets in human soft
tissue tumors. Lab Invest. 95:1077–1088. 2015.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Masumoto N, Kato S, Aichi M, Hasegawa S,
Sahara K, Suyama K, Sano A, Miyazaki T, Okudela K, Kaneko T and
Takahashi T: AMPAR receptor inhibitors suppress proliferation of
human small cell lung cancer cell lines. Thorac Cancer.
14:2897–2908. 2023.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Nygaard V, Prasmickaite L, Vasiliauskaite
K, Clancy T and Hovig E: Melanoma brain colonization involves the
emergence of a brain-adaptive phenotype. Oncoscience. 1:82–94.
2014.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Lynam LM, Lyons MK, Drazkowski JF, Sirven
JI, Noe KH, Zimmerman RS and Wilkens JA: Frequency of seizures in
patients with newly diagnosed brain tumors: A retrospective review.
Clin Neurol Neurosurg. 109:634–638. 2007.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Riva M: Brain tumoral epilepsy: A review.
Neurol Sci. 26 (Suppl 1):S40–S42. 2005.PubMed/NCBI View Article : Google Scholar
|
